April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Effects of Sigma-1 Receptors on Mitochondrial Fusion in Retinal Ganglion Cells
Author Affiliations & Notes
  • Thomas Yorio
    Pharmacology & Neuroscience, North Texas Eye Research Institute, Univ of North Texas Hlth Sci Ctr, Fort Worth, Texas
  • Donald Daudt, III
    Pharmacology & Neuroscience, North Texas Eye Research Institute, Univ of North Texas Hlth Sci Ctr, Fort Worth, Texas
  • Brett Mueller, II
    Pharmacology & Neuroscience, North Texas Eye Research Institute, Univ of North Texas Hlth Sci Ctr, Fort Worth, Texas
  • Footnotes
    Commercial Relationships  Thomas Yorio, None; Donald Daudt, III, None; Brett Mueller, II, None
  • Footnotes
    Support  Department of Defense 5W81XWH-10-2-003
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 4619. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Thomas Yorio, Donald Daudt, III, Brett Mueller, II; Effects of Sigma-1 Receptors on Mitochondrial Fusion in Retinal Ganglion Cells. Invest. Ophthalmol. Vis. Sci. 2011;52(14):4619.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Mitochondrial dysfunction is implicated in many age-related neurological diseases predisposing susceptible neurons to cell death. Maintaining mitochondrial function and mitochondrial distribution in neurites may enhance RGC function by increasing dendrite outgrowth and dendritic spine formations. The purpose of this study is to investigate the role that sigma agonists play in maintaining mitochondrial stability and distribution in neurites, and synaptogenesis under normal physiological and pathological conditions.

Methods: : Primary RGCs were purified and transfected with MitoDsRed and subjected to hypoxia for 6 and 8 hours to observe the effects of hypoxia on the mitochondria. Another set of primary RGCs were pretreated with a s1r agonist prior to hypoxic treatment. Additionally, RGCs under normal conditions transfected with MitoDsRed were subjected to live capture experiments to visualize changes in mitochondrial size and distribution under physiological conditions when treated with a s1r agonist. Immunostaining for surface GluR1 (a marker for active postsynaptic receptors) was performed on primary RGCs treated with a s1r agonist overnight.

Results: : Mitochondria size and neurite distribution were found to decrease in RGCs after hypoxia, while cells treated with pentazocine were able to maintain mitochondria size and distribution throughout the soma and neurites. Additionally, live capture experiments demonstrated enhancement of mitochondrial size and neurite distribution when primary RGCs were treated with a sigma-1 receptor agonist. Overnight treatment of a sigma-1 receptor agonist was found to upregulate plasma membrane expression of GluR1.

Conclusions: : Hypoxia induced mitochondrial fission and decreased mitochondrial distribution in primary RGCs. We hypothesize that s1r agonists exert some of their neuroprotective effects in primary RGCs through their effects on preservation of mitochondrial structure and function. Up regulation of membrane GluR1 expression demonstrates that RGCs treated with a s1r agonist may have a role in synpatogenesis. This also suggest that there may be a link between s1rs, mitochondrial function and increased synaptic formation.

Keywords: mitochondria • receptors • neuroprotection 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×